Pittsburgh Phage Progam (P3)

The mission of the Pittsburgh Phage Program (P3) is to form a multi-disciplinary team to conduct phage discovery, determine phage biology and immunogenicity, identify panels of phage specific multidrug resistant organisms (MDRO), establish ethical framework and conduct clinical trials.  The long-term goal will be to develop phage therapy candidates for major MDRO. Hospitals affiliated with the University of Pittsburgh provide advanced tertiary care for high-risk patients with complex conditions; thus, the P3 program is highly relevant. The Pitt environment provides a unique opportunity to leverage our strengths to create a world-class program in phage therapy.

The Pittsburgh Phage Program is supported by i4Kids and the Pitt Momentum Funds through Pitt Research and the Office of the Provost.

The 2022 Pittsburgh Phage Project Symposium was on Friday, June 3rd, 2022 at the University Club.

Watch the P3 Symposium Recording here

Learn more about registration and abstract submission here

Relevant Funding Opportunities

Find relevant funding opportunities with curated searches below powered by Pivot:

Antimicrobial Resistance

Bacterial Infection


Cystic Fibrosis